Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.340 CAD
−27.81 M CAD
53.91 M CAD
35.88 M
About VALEO PHARMA INC
Sector
CEO
Ali Moghaddam
Headquarters
Kirkland
Website
Founded
2003
FIGI
BBG00NBRD8P8
Valeo Pharma, Inc. engages in the acquisition and in-licensing of branded pharmaceutical and hospital specialty products for sale. Its product portfolio includes respiratory/allergy, specialty products, ophthalmology, neurology, and oncology. The company was founded by Steven Saviuk on March 27, 2003 and is headquartered in Kirkland, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
VPH.DB
VALEO PHARMA INC 12% DEB CNV SUB 31 12% DEB CNV SUB 31/12/2024Yield to maturity
34.25%
Maturity date
Dec 31, 2024
Explore more bonds
Frequently Asked Questions
The current price of VPH is 0.045 CAD — it hasn't changed in the past 24 hours. Watch VALEO PHARMA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange VALEO PHARMA INC stocks are traded under the ticker VPH.
VPH stock hasn't changed in a week, the last month showed zero change in price, over the last year VALEO PHARMA INC has showed a −70.00% decrease.
VPH stock is 0.00% volatile and has beta coefficient of 0.78. Track VALEO PHARMA INC stock price on the chart and check out the list of the most volatile stocks — is VALEO PHARMA INC there?
Today VALEO PHARMA INC has the market capitalization of 4.44 M, it has decreased by −28.57% over the last week.
Yes, you can track VALEO PHARMA INC financials in yearly and quarterly reports right on TradingView.
VALEO PHARMA INC is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
VALEO PHARMA INC revenue for the last quarter amounts to 12.60 M CAD, despite the estimated figure of 13.50 M CAD. In the next quarter, revenue is expected to reach 16.00 M CAD.
VPH net income for the last quarter is −8.19 M CAD, while the quarter before that showed −7.81 M CAD of net income which accounts for −4.88% change. Track more VALEO PHARMA INC financial stats to get the full picture.
No, VPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 125.00 employees. See our rating of the largest employees — is VALEO PHARMA INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VALEO PHARMA INC EBITDA is −16.44 M CAD, and current EBITDA margin is −27.09%. See more stats in VALEO PHARMA INC financial statements.
Like other stocks, VPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VALEO PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VALEO PHARMA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VALEO PHARMA INC stock shows the sell signal. See more of VALEO PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.